ORMP logo
ORMP NASDAQ US

Oramed Pharmaceuticals Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Apr 2002
$3.42
▲ +$0.03 (+0.89%)
Vol 43K
7
Quality Score
fail
Mkt Cap
$113.4M
P/E
2.6
ROE
27.2%
Margin
-382.1%
D/E
0.00
Beta
1.34
52W
$2–$3

Wall Street Consensus

6 analysts · Jun 2025
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

CNTX
Context Therapeutics Inc
$135.1M
NTHI
NeOnc Technologies Holdings Inc
$198.2M
DERM
Journey Medical Corp
$209.2M
ASRT
Assertio Holdings Inc
$58.2M
ANTX
AN2 Therapeutics Inc
$31.2M
LONA
LeonaBio Inc

Earnings

Beat rate: 80.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $0.00 $0.24 +$0.24
Sep 2025 $-0.04 $1.12 +$1.16
Jun 2025 $-0.04 $0.31 +$0.35
Mar 2025 $-0.01 $-0.19 $-0.18

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -16.2% -18.2% -16.2% -16.2% 27.2% 27.2%
P/E (TTM) — — — — 2.50 2.59
Net Margin — -382.1% -382.1% -382.1% -382.1% -382.1%
Gross Margin — 0.7% 0.7% 0.7% 0.7% 0.7%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 26.81 23.94 26.81 26.81 22.25 22.25

Key Ratios

ROA (TTM)
25.6%
P/S (TTM)
56.72
P/B
0.7
EPS (TTM)
$1.01
CF/Share
$-0.42
52W High
$3.24
52W Low
$1.82
$1.82 52-Week Range $3.24

How does ORMP compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

ORMP AARD ACB ACRS ADIL

ORMP valuation vs Pharmaceuticals peers

P/E ratio
2.6
▼ 88% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
56.7
▲ 1046% above peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.7
▼ 69% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

ORMP profitability vs Pharmaceuticals peers

ROE
27.2%
▲ 150% above peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-382.1%
▼ 707% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
0.7%
▼ 99% below peers (68.3%)
vs Peers
vs Industry
Weak
ROA
25.6%
▲ 168% above peers (-37.4%)
vs Peers
vs Industry
Top tier

ORMP financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
22.3
▲ 562% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲ 43% above peers (0.9)
vs Peers
vs Industry
More volatile

ORMP fundamentals radar

ORMP Peer median Industry

ORMP profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ORMP vs peers: key metrics

Latest News

No related news yet